Lenskart Solutions
- Market cap
- ₹ 1,08,959 Cr.
- P/E
- 165.5x
- P/B
- 12.6x
- 52-week range
- 356.1 – 725
- ROE
- 6%
- ROCE
- 8%
- Dividend yield
- 0%
- Debt / equity
- 0.35
- Sector
- Retailing
- Industry
- Speciality Retail
- Listed on
- NSE, BSE
About
Lenskart Solutions Limited, formerly Lenskart Solutions Pvt Ltd, is an India-based eyewear company, which is engaged in designing, manufacturing, branding, and retailing of eyewear products. The Company primarily sells prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories, under multiple brands and sub-brands. Its sunglasses collections include Harry Potter Fashion Essentials, Sports Wear, Havana, Wedding Edit, Holiday Edit, and Pilot. It offers various brands, including Vincent Chase, John Jacobs, Le Petit Lunetier, Aqualens, Bausch Lomb, Soflens, Acuvue, and Fossil. Its focus markets are India, Southeast Asia, Japan, and the Middle East. The Company operates frame and lens design and eyeglass manufacturing facilities at approximately two locations in India, supplemented by regional facilities in Singapore and the United Arab Emirates. It has a presence across channels, including websites, mobile applications, and retail stores.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Speciality Retail: 28 companies →Lenskart Solutions against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)165.5 against a typical 37.3: pricier than most peers (1st = cheapest).27th of 28
- Sales growth+43.3% against a typical +15.4% from a year earlier.4th of 23
- Profit growth+273.8% against a typical +18.3% from a year earlier.1st of 18
- Share price, 3 months+19.7% against a typical −17.4%.6th of 25
- Size₹ 1,08,959 Cr. market value against a typical ₹ 464.2 Cr. (1st = largest).2nd of 27
Latest announcements
Exchange filings and their impact on the company.
- Tiny 0.02% ESOP grant for retention with no meaningful 12-month financial impact.
Lenskart granted 3.42 lakh employee stock options at Rs 508 per share under its 2021 ESOP Plan, approved on October 10, 2026. Each option converts into one Rs 2 equity share on vesting and exercise while in employment. The grant is about 0.02% of shares outstanding, so dilution and cost are negligible while supporting employee retention.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 4 Nov 2026Upcoming | Financial Results | To consider and approve the financial results for the quarter and half-year ended September 30, 2026 |
| 12 Aug 2026 | Financial Results | To consider and approve the financial results for the quarter ended June 30, 2026 |
| 20 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 11 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 29 Nov 2025 | Financial Results | To consider and approve the financial results for the quarter and half-year ended September 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,736 | 1,669 | 1,728 | 1,894 | 2,096 | 2,308 | 2,516 | 2,714 |
| Expenses | 1,449 | 1,459 | 1,436 | 1,558 | 1,683 | 1,845 | 1,979 | 2,126 |
| Operating Profit | 286 | 210 | 292 | 336 | 413 | 462 | 536 | 588 |
| OPM % | 16% | 13% | 17% | 18% | 20% | 20% | 21% | 22% |
| Other Income | 70 | 32 | 212 | 42 | 33 | 35 | 49 | 69 |
| Interest | 26 | 34 | 48 | 41 | 45 | 49 | 44 | 53 |
| Depreciation | 196 | 199 | 215 | 237 | 253 | 270 | 288 | 305 |
| Profit before tax | 134 | 8 | 241 | 100 | 148 | 178 | 254 | 300 |
| Tax % | 36% | 77% | 9% | 39% | 30% | 26% | 20% | 24% |
| Net Profit | 86 | 2 | 220 | 61 | 103 | 133 | 204 | 228 |
| EPS in Rs | 11.08 | 0.02 | 2.84 | 0.78 | 1.24 | 0.76 | 1.15 | 1.28 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 58%
- 3 Years
- 33%
- TTM
- 37%
- 10 Years
- —
- 5 Years
- 74%
- 3 Years
- 110%
- TTM
- 77%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 2%
- 3 Years
- 4%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Lenskart Solutions | ₹ 688.35 | ₹ 1,08,959 Cr. | 165.5x | 12.6x | 6% | — |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 52.1x | 5.5x | 11% | 17.1% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 35.6x | 5x | 12.8% | 9.5% |
| One Global Service Provider | ₹ 372.00 | ₹ 721 Cr. | 17x | 8.3x | 65.2% | 14% |
| Mallcom (India) | ₹ 909.00 | ₹ 567 Cr. | 21.9x | 2.1x | 9.7% | 5.6% |
| Hemant Surgical Industries | ₹ 570.00 | ₹ 829 Cr. | 26x | 3.7x | 18.1% | 7.9% |
Management
- Peyush Bansal
- Executive Chairman of the Board, Chief Executive Officer, Managing Director
- Abhishek Gupta
- Chief Financial Officer
- Ashish Srivastava
- Compliance Officer, Company Secretary
- Neha Bansal
- Executive Director
- Amit Chaudhary
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.